Global Oxygen Therapy and Respiratory Care Devices Market Research Report by Treatment Type, by Technology, by Device Portability, by Indication, by End User, and by Region Forecast till 2035

Description

List of Tables

The Global Oxygen Therapy and Respiratory Care Devices Market was valued at USD 37,568.69 million in 2025 and is projected to reach USD 74,419.59 million by 2035, registering a CAGR of 7.09% during the forecast period of 2025-2035.

Rising Prevalence of Chronic Respiratory Diseases

The rising incidence of chronic respiratory diseases such as COPD, asthma, pulmonary fibrosis, and obstructive sleep apnea is fueling the demand for respiratory care devices across hospitals and home healthcare settings. Moreover, there is a very significant worldwide burden of asthma, affecting about 363 million people in 2023, which shows the growing demand for effective respiratory support and oxygen supply solutions.

Segment-wise Market Analysis

By Treatment Type

Intelligent Oxygen Delivery Systems: Optimize oxygen delivery through intelligent flow adjustments.
Oxygen Concentrators: Provide continuous oxygen from ambient air.
Compressed Oxygen Cylinders: Ensure reliable oxygen supply during respiratory emergencies.
Liquid Oxygen Systems: Store oxygen efficiently for prolonged respiratory support.
Oxygen Conserving Devices: Reduce oxygen wastage while maintaining therapeutic delivery.
Oxygen Flow Controllers: Regulate oxygen flow according to patient requirements.
Ventilators: Support breathing in patients with respiratory failure.
CPAP/BiPAP Devices: Maintain airway pressure and improve breathing efficiency.
Nebulizers: Deliver inhaled medications directly into the lungs.
Humidifiers: Maintain airway moisture during respiratory support.
Respiratory Monitoring Devices: Track respiratory parameters for timely clinical intervention.
Airway Management Devices: Maintain airway patency during respiratory treatment.
Consumables and Accessories: Support device functionality through essential replacement components.

By Technology

Continuous Flow: Deliver oxygen continuously at prescribed flow rates.
Pulse Dose: Release oxygen during detected inhalation cycles.
Demand Flow: Supply oxygen according to patient breathing patterns.
AI-enabled: Improve respiratory support through intelligent data analysis.
Closed-loop: Automatically adjust therapy using real-time physiological feedback.
Others: Incorporate alternative technologies for specialized respiratory applications.

By Device Portability

Stationary: Provide reliable respiratory support within fixed care environments.
Portable: Enable convenient respiratory therapy during everyday activities.

By Indication

Chronic Obstructive Pulmonary Disease: Support breathing management in patients with COPD.
Asthma: Facilitate respiratory management during asthma exacerbations.
Obstructive Sleep Apnea (OSA): Maintain airway patency during sleep.
Pneumonia: Provide respiratory support during severe pulmonary infections.
Pulmonary Fibrosis: Improve oxygenation in patients with lung scarring.
Respiratory Distress Syndrome (ARDS/RDS): Support oxygenation during acute respiratory distress.
Cystic Fibrosis: Assist airway clearance and respiratory function management.
Others: Address additional conditions requiring specialized respiratory support.

By End User

Hospitals: Deliver comprehensive respiratory care across inpatient departments.
Ambulatory Surgical Centers: Provide respiratory support during outpatient surgical procedures.
Home Healthcare: Enable convenient respiratory treatment within residential settings.
Emergency Medical Facilities: Deliver immediate respiratory support during critical emergencies.
Long-term Care Facilities: Support ongoing respiratory management for dependent patients.
Others: Serve specialized facilities requiring respiratory care equipment.

Regional Analysis

North America leads the global oxygen therapy and respiratory care devices market with a market size of USD 15, 263. 19 million in 2025. This position can be attributed to the fact that home oxygen therapy has become increasingly popular while AI-enabled healthcare technologies have also made their way into this sphere. Asia-Pacific is estimated to be the fastest-growing market at a CAGR of 9.21% through 2035 which, in turn, is the effect of the improvement of healthcare infrastructure and the increase of access to respiratory care.

Inogen Expands Stationary Oxygen Therapy Portfolio

In June 2025, Inogen, Inc. announced the launch of the Voxi 5 oxygen concentrator. The new stationary oxygen concentrator was developed specifically to enhance patients' access to high-flux oxygen therapy and, thereby, strengthen Inogen's presence in the respiratory care market.

Expanding Access to Oxygen Therapy in Underserved Regions

The innovation of energy-efficient oxygen concentrators that also function when the electricity power gets interrupted through battery backup, solar compatibility, and simplified upkeep provides great potential for manufacturers in terms of overcoming respiratory care challenges in geographically remote, resource-limited settings.

Key Report Attributes

Market Size 2025: USD 37,568.69 Million
Market Size 2035: USD 74,419.59 Million
CAGR (2025-2035): 7.09%
Base Year: 2024
Market Forecast Period: 2025-2035

Market Segmentations Growth

By Treatment Type: Oxygen Therapy Devices - 6.53%, Respiratory Care Devices - 7.73%.
By Technology: Continuous Flow - 6.58%, Pulse Dose - 8.19%.
By Device Portability: Stationary - 6.35%, Portable - 8.13%.
By Indication: Chronic Obstructive Pulmonary Disease - 7.24%, Asthma - 5.97%.
By End User: Hospitals - 7.06%, Ambulatory Surgical Centers - 4.84%.

Product Code: MRFRMED66596CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 Research Objective
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 Overview
3.2 DATA flow
- 3.2.1 DATA MINING PROCESS
3.3 Purchased Database:
3.4 Secondary Sources:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 Primary Research:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.5.4 REVENUE ANALYSIS APPROACH
3.6 Data forecasting
- 3.6.1 DATA FORECASTING TYPE
3.7 Data modeling
- 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.7.2 DATA MODELING:
3.1 Teams and Analyst Contribution

4 MARKET DYNAMICS

4.1 Introduction
4.2 Drivers
- 4.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES (COPD, ASTHMA, PULMONARY FIBROSIS) GLOBALLY
- 4.2.2 AGING POPULATION INCREASING DEMAND FOR LONG-TERM OXYGEN THERAPY AND HOME RESPIRATORY CARE
- 4.2.3 GROWTH IN HOSPITAL AND CRITICAL-CARE CAPACITY AND ICU UTILIZATION REQUIRING SUPPLEMENTAL OXYGEN AND AUTOMATED RESPIRATORY SUPPORT SYSTEMS
- 4.2.4 TECHNOLOGICAL ADVANCEMENTS IN AUTOMATED BREATHING DEVICES (SMART VENTILATION, AI INTEGRATION, PORTABLE SYSTEMS, MONITORING, AND SAFETY FEATURES)
4.3 Restraints
- 4.3.1 HIGH UPFRONT COST AND REIMBURSEMENT VARIABILITY FOR HOME OXYGEN 0SYSTEMS ACROSS COUNTRIES
- 4.3.2 STRICT REGULATORY REQUIREMENTS AND APPROVAL TIMELINES FOR AUTOMATED BREATHING DEVICES AND MONITORING ACCESSORIES
- 4.3.3 SAFETY-RELATED LIABILITIES AND STRINGENT HANDLING REQUIREMENTS FOR OXYGEN (FIRE HAZARD, TRANSPORT, AND STORAGE CONTROLS)
4.4 Opportunities
- 4.4.1 HOME AND AMBULATORY OXYGEN WORKFLOW SOLUTIONS (REMOTE MONITORING, ADHERENCE SUPPORT, TELEHEALTH INTEGRATION)
- 4.4.2 LONG-LIFE, LOW-MAINTENANCE OXYGEN CONCENTRATORS FOR OFF-GRID AND LOW-POWER SETTINGS

5 MARKET FACTOR ANALYSIS

5.1 Porter's Five Forces Model
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 Technology Outlook and Disruptions
5.3 CUSTOMER NEEDS ASSESSMENT
5.4 REGULATORY LANDSCAPE
5.5 Reimbursement Landscape
5.6 Innovation & Patent Landscape
5.7 Market Entry Strategy
- 5.7.1 COUNTRY PRIORITIZATION
- 5.7.2 REGULATORY SEQUENCING
- 5.7.3 PRICING
- 5.7.4 PARTNERSHIPS
- 5.7.5 LAUNCH ROADMAP
5.8 Patient Demographics, By Major Countries
- 5.8.1 UNITED STATES
- 5.8.2 EU5 (GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN)
- 5.8.3 CHINA
- 5.8.4 INDIA
- 5.8.5 JAPAN
- 5.8.6 SOUTH KOREA
- 5.8.7 UNITED ARAB EMIRATES (UAE)
- 5.8.8 SOUTH AFRICA
5.9 PESTLE ANALYSIS
- 5.9.1 POLITICAL FACTORS
- 5.9.2 ECONOMIC FACTORS
- 5.9.3 SOCIAL FACTORS
- 5.9.4 TECHNOLOGICAL FACTORS
- 5.9.5 LEGAL FACTORS
- 5.9.6 ENVIRONMENTAL FACTORS

6 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY PRODUCT

6.1 Overview

7 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY TECHNOLOGY

7.1 Overview

8 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY DEVICE PORTABILITY

8.1 Overview

9 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY INDICATION

9.1 Overview

10 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY END USER

10.1 Overview

11 GLOBAL OXYGEN THERAPY AND RESPIRATORY CARE DEVICES MARKET, BY REGION

11.1 Overview
11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.2 CANADA
11.3 europe
- 11.3.1 GERMANY
- 11.3.2 UK
- 11.3.3 FRANCE
- 11.3.4 NETHERLANDS
- 11.3.5 ITALY
- 11.3.6 SPAIN
- 11.3.7 REST OF EUROPE
11.4 asia pacific
- 11.4.1 CHINA
- 11.4.2 INDIA
- 11.4.3 JAPAN
- 11.4.4 SOUTH KOREA
- 11.4.5 MALAYSIA
- 11.4.6 THAILAND
- 11.4.7 INDONESIA
- 11.4.8 REST OF ASIA PACIFIC
11.5 South America
- 11.5.1 BRAZIL
- 11.5.2 MEXICO
- 11.5.3 ARGENTINA
- 11.5.4 REST OF SOUTH AMERICA
11.6 Middle East & Africa
- 11.6.1 GCC COUNTRIES
- 11.6.2 SOUTH AFRICA
- 11.6.3 REST OF MIDDLE EAST AND AFRICA

12 COMPETITIVE LANDSCAPE

12.1 Introduction
12.2 Market Share Analysis, 2025
12.3 competitor dashboard
12.4 Public Players Stock Summary
12.5 Comparative Analysis: Key Players Financial
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 12.6.1 PRODUCT LAUNCH
- 12.6.2 PRODUCT EXPANSION

13 COMPANY PROFILES

13.1 Koninklijke Philips N.V.
- 13.1.1 COMPANY OVERVIEW
- 13.1.2 FINANCIAL OVERVIEW
- 13.1.3 PRODUCTS OFFERED
- 13.1.1 KEY DEVELOPMENTS
- 13.1.2 SWOT ANALYSIS
- 13.1.3 KEY STRATEGIES
13.2 CAIRE Inc.
- 13.2.2 FINANCIAL OVERVIEW
- 13.2.4 KEY DEVELOPMENTS
- 13.2.5 SWOT ANALYSIS
13.3 Inogen, Inc.
- 13.3.1 COMPANY OVERVIEW
- 13.3.2 FINANCIAL OVERVIEW
- 13.3.3 PRODUCTS OFFERED
- 13.3.4 KEY DEVELOPMENTS
- 13.3.5 SWOT ANALYSIS
- 13.3.6 KEY STRATEGIES
13.4 GE HealthCare
- 13.4.1 COMPANY OVERVIEW
- 13.4.2 FINANCIAL OVERVIEW
- 13.4.3 PRODUCTS OFFERED
- 13.4.4 KEY DEVELOPMENTS
- 13.4.5 SWOT ANALYSIS
- 13.4.6 KEY STRATEGIES
13.5 ResMed
- 13.5.1 COMPANY OVERVIEW
- 13.5.2 FINANCIAL OVERVIEW
- 13.5.3 PRODUCTS OFFERED
- 13.5.4 KEY DEVELOPMENTS
- 13.5.5 SWOT ANALYSIS
- 13.5.6 KEY STRATEGIES
13.6 Dynasthetics, Inc.
- 13.6.1 COMPANY OVERVIEW
- 13.6.2 FINANCIAL OVERVIEW
- 13.6.3 PRODUCTS OFFERED
- 13.6.4 KEY DEVELOPMENTS
- 13.6.5 KEY STRATEGIES
13.7 Medtronic
- 13.7.1 COMPANY OVERVIEW
- 13.7.2 FINANCIAL OVERVIEW
- 13.7.3 PRODUCTS OFFERED
- 13.7.4 KEY DEVELOPMENTS
- 13.7.5 KEY STRATEGIES
13.8 Getinge AB
- 13.8.1 COMPANY OVERVIEW
- 13.8.2 FINANCIAL OVERVIEW
- 13.8.3 PRODUCTS OFFERED
- 13.8.4 KEY DEVELOPMENTS
- 13.8.5 KEY STRATEGIES
13.9 Dragerwerk AG & Co. KGaA
- 13.9.1 COMPANY OVERVIEW
- 13.9.2 FINANCIAL OVERVIEW
- 13.9.3 PRODUCTS OFFERED
- 13.9.4 KEY DEVELOPMENTS
- 13.9.5 KEY STRATEGIES
13.10 Precision Medical, Inc.
- 13.10.1 COMPANY OVERVIEW
- 13.10.2 FINANCIAL OVERVIEW
- 13.10.3 PRODUCTS OFFERED
- 13.10.4 KEY DEVELOPMENTS
- 13.10.5 KEY STRATEGIES

14 DATA CITATIONS